SEGMENT AND GEOGRAPHIC DATA

We segregate our operations into three reportable business segments: Orthopaedics, MedSurg, and Neurotechnology and Spine.

The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.



Segment Results
	2017			2016			2015
Orthopaedics	$	4,713		$	4,422		$	4,223
MedSurg	5,557			4,894			3,895
Neurotechnology & Spine	2,174			2,009			1,828
Net sales	$	12,444		$	11,325		$	9,946
Orthopaedics	$	337		$	317		$	290
MedSurg	315			249			117
Neurotechnology & Spine	142			140			132
Segment depreciation and amortization	$	794		$	706		$	539
Corporate and Other	65			46			51
Total depreciation and amortization	$	859		$	752		$	590
Orthopaedics	$	1,669		$	1,597		$	1,487
MedSurg	1,225			1,085			822
Neurotechnology & Spine	639			557			474
Segment operating income	$	3,533		$	3,239		$	2,783
Items not allocated to segments:
Corporate and Other	$	(402	)	$	(352	)	$	(302	)
Acquisition & integration-related charges	(64		)	(131		)	(35		)
Amortization of intangible assets	(371		)	(319		)	(210		)
Restructuring related-charges	(194		)	(125		)	(132		)
Rejuvenate and related-charges	(173		)	(158		)	(296		)
Regulatory and legal matters	(39		)	12			53
Consolidated operating income	$	2,290		$	2,166		$	1,861



Segment Assets and Capital Spending
Assets:	2017		2016		2015
Orthopaedics	$	7,486	$	7,048	$	6,149
MedSurg	9,759		8,553		5,341
Neurotechnology & Spine	4,105		4,129		3,904
Total segment assets	$	21,350	$	19,730	$	15,394
Corporate and Other	847		705		829
Total assets	$	22,197	$	20,435	$	16,223
Capital spending:
Orthopaedics	$	138	$	153	$	95
MedSurg	194		129		89
Neurotechnology & Spine	50		25		28
Total segment capital spending	$	382	$	307	$	212
Corporate and Other	216		183		58
Total capital spending	$	598	$	490	$	270

We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related charges, reserves for certain product recall matters, reserves for certain legal and regulatory matters and a donation to an educational institution. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally cash and cash equivalents, marketable securities and property, plant and equipment.

The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based off the geographic area of the Stryker location where the sales to the customer originated.



Geographic Information
	Net Sales						Net Property, Plant and Equipment
	2017		2016		2015		2017		2016
United States	$	9,059	$	8,230	$	7,116	$	1,102	$	941
Europe, Middle East, Africa	1,567		1,437		1,267		718		493
Asia Pacific	1,413		1,325		1,251		107		105
Other countries	405		333		312		48		30
Total	$	12,444	$	11,325	$	9,946	$	1,975	$	1,569